364 related articles for article (PubMed ID: 27473757)
21. Characterization of patients at high risk of melanoma in Austria.
Müller C; Wendt J; Rauscher S; Burgstaller-Muehlbacher S; Sunder-Plassmann R; Scheurecker C; Richtig E; Fae I; Fischer G; Pehamberger H; Okamoto I
Br J Dermatol; 2016 Jun; 174(6):1308-17. PubMed ID: 26800492
[TBL] [Abstract][Full Text] [Related]
22. Genotype analysis in Hungarian patients with multiple primary melanoma.
Hatvani Z; Brodszky V; Mazán M; Pintér D; Hársing J; Tóth V; Somlai B; Kárpáti S
Exp Dermatol; 2014 May; 23(5):361-4. PubMed ID: 24660985
[TBL] [Abstract][Full Text] [Related]
23. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
[TBL] [Abstract][Full Text] [Related]
25. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Auroy S; Avril MF; Chompret A; Pham D; Goldstein AM; Bianchi-Scarrà G; Frebourg T; Joly P; Spatz A; Rubino C; Demenais F; Bressac-de Paillerets B;
Genes Chromosomes Cancer; 2001 Nov; 32(3):195-202. PubMed ID: 11579459
[TBL] [Abstract][Full Text] [Related]
26. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
Ghiorzo P; Pastorino L; Queirolo P; Bruno W; Tibiletti MG; Nasti S; Andreotti V; ; Paillerets BB; Bianchi Scarrà G
Pigment Cell Melanoma Res; 2013 Mar; 26(2):259-62. PubMed ID: 23167872
[TBL] [Abstract][Full Text] [Related]
28. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
[TBL] [Abstract][Full Text] [Related]
29. The lack of E318K MITF germline mutation in Latvian melanoma patients.
Ozola A; Pjanova D
Cancer Genet; 2015 Jun; 208(6):355-6. PubMed ID: 25975176
[No Abstract] [Full Text] [Related]
30. Skin Pigmentation Genetics for the Clinic.
Ainger SA; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
Dermatology; 2017; 233(1):1-15. PubMed ID: 28463841
[TBL] [Abstract][Full Text] [Related]
31. Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.
Puig S; Potrony M; Cuellar F; Puig-Butille JA; Carrera C; Aguilera P; Nagore E; Garcia-Casado Z; Requena C; Kumar R; Landman G; Costa Soares de Sá B; Gargantini Rezze G; Facure L; de Avila AL; Achatz MI; Carraro DM; Duprat Neto JP; Grazziotin TC; Bonamigo RR; Rey MC; Balestrini C; Morales E; Molgo M; Bakos RM; Ashton-Prolla P; Giugliani R; Larre Borges A; Barquet V; Pérez J; Martínez M; Cabo H; Cohen Sabban E; Latorre C; Carlos-Ortega B; Salas-Alanis JC; Gonzalez R; Olazaran Z; Malvehy J; Badenas C
Genet Med; 2016 Jul; 18(7):727-36. PubMed ID: 26681309
[TBL] [Abstract][Full Text] [Related]
32. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
33. Ocular melanoma is not associated with CDKN2A or MC1R variants--a population-based study.
Vajdic C; Kricker A; Duffy DL; Aitken JF; Stark M; ter Huurne JA; Martin NG; Armstrong BK; Hayward NK
Melanoma Res; 2003 Aug; 13(4):409-13. PubMed ID: 12883368
[TBL] [Abstract][Full Text] [Related]
34. Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
Maubec E; Chaudru V; Mohamdi H; Blondel C; Margaritte-Jeannin P; Forget S; Corda E; Boitier F; Dalle S; Vabres P; Perrot JL; Lyonnet DS; Zattara H; Mansard S; Grange F; Leccia MT; Vincent-Fetita L; Martin L; Crickx B; Joly P; Thomas L; ; Bressac-de Paillerets B; Avril MF; Demenais F
J Am Acad Dermatol; 2012 Dec; 67(6):1257-64. PubMed ID: 22841127
[TBL] [Abstract][Full Text] [Related]
35. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
36. MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.
Pellegrini C; Fargnoli MC; Suppa M; Peris K
BMC Med Genet; 2012 Sep; 13():81. PubMed ID: 22978401
[TBL] [Abstract][Full Text] [Related]
37. [Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma].
Avril MF; Bahadoran P; Cabaret O; Caron O; de la Fouchardière A; Demenais F; Desjardins L; Frébourg T; Hammel P; Leccia MT; Lesueur F; Mahé E; Martin L; Maubec E; Remenieras A; Richard S; Robert C; Soufir N; Stoppa-Lyonnet D; Thomas L; Vabres P; Bressac-de Paillerets B
Ann Dermatol Venereol; 2015 Jan; 142(1):26-36. PubMed ID: 25600792
[TBL] [Abstract][Full Text] [Related]
38. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
39. Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients.
Ciccarese G; Dalmasso B; Bruno W; Queirolo P; Pastorino L; Andreotti V; Spagnolo F; Tanda E; Ponti G; Massone C; Drago F; Parodi A; Ghigliotti G; Pizzichetta MA; Ghiorzo P;
J Transl Med; 2020 Feb; 18(1):78. PubMed ID: 32054529
[TBL] [Abstract][Full Text] [Related]
40. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
